01—Abstract
Summary
Summary of the 8-K filed September 21, 2026. Cited figures are marked; the original filing is the authoritative source.
Axon Enterprise, Inc. has announced the successful issuance and sale of $1,150.0 milliona in aggregate principal amount of 0% Convertible Senior Notes due 2031.
This offering, which included the full exercise of an over-allotment option by underwriters, was made under a shelf registration statement and closed on September 18, 2026. The company plans to use approximately $114.9 millionb of the net proceeds to fund capped call transactions designed to mitigate potential dilution, with the remainder allocated for general corporate purposes, including growth initiatives and potential acquisitions. The notes are convertible into Axon's Common Stock at an initial rate of 1.5336 shares per $1,000 principal amount, implying an initial conversion price of approximately $652.06 per share.
The notes do not bear regular interest, but the company may pay special interest as a remedy for reporting obligation failures. The debt matures on September 15, 2031, unless converted, redeemed, or repurchased earlier. The company also entered into capped call transactions to reduce potential dilution and offset potential cash payments upon conversion.
02—Key points
Key Highlights
- Axon Enterprise, Inc. successfully priced and closed an offering of $1,150 million in 0% Convertible Senior Notes due 2031.
- The offering includes an additional $150 million from the full exercise of the underwriters' over-allotment option.
- Net proceeds are allocated for capped call transactions ($114.9 million) and general corporate purposes, including growth and acquisitions.
- The notes are convertible into Axon's Common Stock at an initial conversion price of approximately $652.06 per share.
- The notes carry a 0% interest rate, with special interest payable only as a remedy for reporting defaults.
- The company has entered into capped call transactions to mitigate potential shareholder dilution from the convertible notes.
- The notes are unsecured general obligations of the company and are structurally junior to subsidiary debt.
03—Questions
Frequently Asked Questions
What is the purpose of the 0% Convertible Senior Notes offering?
The primary purposes of the offering are to raise capital for general corporate purposes, including supporting growth and potential acquisitions, and to finance capped call transactions. These capped call transactions are intended to mitigate potential dilution to existing shareholders upon conversion of the notes.
What is the conversion price and how does it compare to Axon's current stock price?
The initial conversion price for the notes is approximately $652.06 per share. This information should be compared to Axon's current trading price to assess the in-the-money or out-of-the-money status of the conversion feature.
Does Axon have to pay interest on these notes?
The notes carry a 0% regular interest rate, meaning no periodic interest payments are made. However, the company may elect to pay 'special interest' as the sole remedy for its failure to comply with its reporting obligations. This special interest would be payable semiannually in arrears.
What are the risks associated with these convertible notes for Axon?
Key risks include potential dilution if the stock price rises significantly and triggers conversions, the obligation to potentially pay a premium for repurchases or redemptions, and the fact that the notes are unsecured general obligations, making them junior to secured debt and structurally junior to debt and liabilities of subsidiaries.
04—Continue